Reaction Details |
| Report a problem with these data |
Target | Cytochrome P450 2D6 |
---|
Ligand | BDBM50446471 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1287805 (CHEMBL3111800) |
---|
IC50 | >39000±n/a nM |
---|
Citation | Bürli, RW; Luckhurst, CA; Aziz, O; Matthews, KL; Yates, D; Lyons, KA; Beconi, M; McAllister, G; Breccia, P; Stott, AJ; Penrose, SD; Wall, M; Lamers, M; Leonard, P; Müller, I; Richardson, CM; Jarvis, R; Stones, L; Hughes, S; Wishart, G; Haughan, AF; O'Connell, C; Mead, T; McNeil, H; Vann, J; Mangette, J; Maillard, M; Beaumont, V; Munoz-Sanjuan, I; Dominguez, C Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease. J Med Chem56:9934-54 (2013) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Cytochrome P450 2D6 |
---|
Name: | Cytochrome P450 2D6 |
Synonyms: | CP2D6_HUMAN | CYP2D6 | CYP2DL1 | CYPIID6 | Cytochrome P450 2D6 (CYP2D6) | Debrisoquine 4-hydroxylase | P450-DB1 |
Type: | Protein |
Mol. Mass.: | 55774.82 |
Organism: | Homo sapiens (Human) |
Description: | P10635 |
Residue: | 497 |
Sequence: | MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVDFQNTPYCFDQ
LRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVF
LARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDK
AVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKV
LRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVA
DLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVI
HEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHF
LDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGV
FAFLVSPSPYELCAVPR
|
|
|
BDBM50446471 |
---|
n/a |
---|
Name | BDBM50446471 |
Synonyms: | CHEMBL3109984 | US9765054, Compound 75a |
Type | Small organic molecule |
Emp. Form. | C20H18N2O3 |
Mol. Mass. | 334.3685 |
SMILES | Cc1ncc(o1)-c1ccc(cc1)[C@H]1[C@@H]([C@@H]1c1ccccc1)C(=O)NO |r| |
Structure |
|